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Abstract.  To explore the possible role of proteolytic 
step(s) in receptor-mediated endocytosis of insulin,  the 
effects of inhibitors  of various classes of proteases on 
the internalization  process were studied in isolated rat 
adipocytes. Intracellular accumulation of receptor- 
bound 125I-insulin at 37°C was quantitated after rapidly 
dissociating surface-bound insulin with an acidic buffer 
(pH 3.0).  Of the 23 protease inhibitors tested, only 
chymotrypsin substrate analogues inhibited insulin in- 
ternalization.  Internalization  was decreased 62-90%  by 
five different chymotrypsin substrate analogues: 
N-acetyl-Tyr ethyl ester, N-acetyl-Phe ethyl ester, 
N-acetyl-Trp ethyl ester, benzoyl-Tyr ethyl ester, and 
benzoyl-Tyr amide.  The effect of the substrate ana- 
logues in inhibiting  insulin internalization  was dose- 
dependent,  reversible,  and required the full structural 
complement of a chymotrypsin substrate analogue. 
Cell surface receptor number was unaltered at  12°C. 
However, concomitant with their inhibition of insulin 
internalization  at 37°C,  the chymotrypsin substrate an- 
alogues caused a marked increase (160-380%) in 
surface-bound insulin,  indicating trapping of insu- 
lin-receptor complexes on the cell surface.  Addition- 
ally,  1 mM N-acetyl-Tyr ethyl ester decreased overall 
insulin degradation by 15-20%  and also prevented the 
chloroquine-mediated increase in intracellular  insulin, 
further indicating that surface-bound insulin was 
prevented from reaching  intracellular  chloroquine- 
sensitive degradation  sites. The internalization  of insu- 
lin receptors that were photoaffinity labeled on the cell 
surface with B2(2-nitro-4-azidophenylacetyl)-des- 
PheBt-insulin  was also inhibited 70-90%  by the five 
chymotrypsin substrate analogues,  as determined by 
the effects of the analogues on the accumulation of 
trypsin-insensitive (intracellular)  440-kD intact labeled 
receptors.  In summary, these results show that 
chymotrypsin substrate analogues efficiently inhibit the 
internalization  of insulin and insulin receptors in 
adipocytes and implicate a possible role for endoge- 
nous chymotrypsin-like enzyme(s) or related sub- 
stances in receptor-mediated endocytosis of insulin. 
I 
NTERNALIZATION of ligands  selectively  bound to cell 
surface receptors occurs through  the process of recep- 
tor-mediated endocytosis.  Ligands  for which this pro- 
cess has been widely studied are polypeptide growth factors 
and hormones, including insulin,  nutrient transport proteins 
such as low density lipoprotein  and transferrin,  asialoglyco- 
proteins and immunoglobulins  (reviewed in references 5, 17, 
36,  43,  44).  For ligands  such as low density lipoprotein, 
transferrin,  and asialoglycoproteins,  endocytosis serves the 
function of delivering  extracellular  molecules to the cell in- 
terior for further metabolic usage or degradation.  However, 
the physiologic  role of internalization  of insulin  and other 
polypeptide  hormones  remains  incompletely  understood. 
One  important  function  of  the  internalization  of  insu- 
lin-receptor complexes  is believed to be mediation  of the 
insulin-induced  receptor  loss  (down-regulation)  that  has 
been extensively demonstrated in various cell types, includ- 
ing adipocytes (15, 18, 24, 29). Other potential  functions  of 
the internalization  process may include the termination of in- 
sulin action by removing the hormone from the cell surface 
and transporting  it to intracellular  degradation  sites and/or 
mediating the intracellular  effects of the hormone (5, 34, 40). 
Thus,  characterization  of the  internalization  of  insulin- 
receptor complexes is of importance in further understand- 
ing its role in the physiologic regulation  of insulin receptors 
and insulin  action. 
In various studies  of receptor-mediated endocytosis,  sev- 
eral factors that inhibit the endocytotic process have been de- 
scribed.  These include  inhibitors  of metabolic energy (27, 
33, 36),  depletion of intracellular  potassium (26, 27),  sulf- 
hydryl reagents (22, 42), hypertonic media (11), and transglu- 
taminase  inhibitors  (12, 19). Although  energy  depletion, 
potassium  depletion,  sulfhydryl  reagents,  and  hypertonic 
media effectively inhibit endocytosis,  they pose the possible 
problem of nonselectively affecting  multiple  cellular pro- 
cesses. Although  potentially  more selective,  transglutamin- 
ase inhibitors, which have been reported to block internaliza- 
tion of several other ligands  (12, 19), do not inhibit  insulin 
internalization  in isolated  rat adipocytes  (14). Additionally, 
many of the effects of these agents have been attributed to in- 
hibition of receptor recycling, rather than to inhibition of en- 
docytosis (41). 
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insulin internalization and to identify agents that block the 
process in the adipocyte, a major insulin-sensitive cell, we 
have examined the effects of protease inhibitors. Protease in- 
hibitors were considered possible blockers of endocytosis 
since they inhibit other cellular processes dependent upon 
vesicular movement and membrane fusion. For example, in- 
hibitors of metalloendoproteases prevent the fusion of myo- 
blasts into myotubules (10) as well as the exocytotic release 
of transmitters from presynaptic nerve terminals (3), hista- 
mine from mast ceils, and catecholamines from adrenal cells 
(31). Synthetic tripeptide aldehyde protease inhibitors have 
also been shown to block the exocytotic release of prolactin 
from cultured pituitary cells (32).  Since endocytosis also in- 
volves vesicular movements and requires a membrane fusion 
event, the joining of segments of the plasma membrane to 
form endocytotic vesicles, we hypothesized that a proteolytic 
step  may  be  required  during  the  endocytosis  of  insu- 
lin-receptor complexes. To test this hypothesis, we studied 
the effects of inhibitors of various classes of proteases on the 
internalization of insulin and insulin receptors in isolated rat 
adipocytes. Our results show that compounds that are com- 
petitive inhibitors of chymotrypsin-like enzymes prevent the 
internalization of insulin-receptor complexes in adipocytes. 
Materials and Methods 
Materials 
Na~25I was purchased from Amersham Corp. (Arlington Heights, IL); col- 
lagenase  from Worthington Biochemical Corp.  (Freehold,  NJ);  Eagle's 
minimum essential medium (MEM) from Gibco (Grand Island, NY); bo- 
vine serum albumin (BSA, Fraction V) from Armour Pharmaceutical Co. 
(Tarrytown, NY); silicone oil from Arthur H. Thomas Co. (Philadelphia, 
PA); IODO-GEN from Pierce Chemical Co. (Rockford, IL); phosphorami- 
don from Enzyme Systems Products (Livermore, CA); and dimethyl sulf- 
oxide, monodansyleadaverine, and methylamine from Sigma Chemical Co. 
(St. Louis, MO). Porcine monocomponent  insulin was supplied by Dr. Ron- 
aid Chance of Eli Lilly & Co. (Indianapolis, IN). All other protease inhibi- 
tors and protease substrate analogues were obtained from Vega Biotechnolo- 
gies, Inc.  (Tucson, AZ) or Sigma Chemical Co. The photoreactive insulin 
derivative,  B2  (2-nitro-4-azidophenylacetyl)-des-PheBl-insulin (NAPA- 
DP-insulin), ~ which has been well characterized and is fully biologically 
active  (8,  13), was  kindly  provided  by  Dr.  Dietrich  Brandenburg  of 
Deutsches Wollforschungsinstitut, Aachen, Federal Republic of Germany. 
Iodination of  Insulin and Photoreactive 
Insulin Derivative 
Insulin and NAPA-DP-insulin were each iodinated to a specific activity of 
,'~200 ~tCi/ug using the water-insoluble oxidizing agent, 1,3,4,6-tetrachloro- 
3¢t,6ct-diphenylglycoluril  (IODO-GEN), essentially as we have described 
previously (6, 7).  ~25I-insulin was chromatographed on a  Sephadex G-50 
column to remove free t25I. NAPA-Dp-t25I-insulin  was dialyzed overnight 
at 4°C in a dark room to remove free t25I and the iodinated product was 
stored protected from light at 4°C and used within 3 wk. 
Preparation of  lsolated Adipocytes 
Isolated adipocytes were prepared by collagenase digestion (35) of epidid- 
ymal fat pads obtained from male Sprague-Dawley rats weighing 200-240 
g. The cells were filtered through a 250-I.tm nylon mesh, washed four times, 
and suspended in a binding buffer (pH 7.6) consisting of MEM,  10 mM 
Hepes, and 1% BSA. Adipocyte counts were performed after fixing the cells 
in 2% osmium tetroxide/0.05 M collidine/0.9 % NaCI buffer using a model 
ZB Coulter Counter (Coulter Electronics, Inc., Hialeah, FL) as previously 
described (7, 21). 
1. Abbreviation used in this paper:  NAPA-DP-insulin, B2(2-nitro-4-azido- 
phenylacetyl)-des-PheB  ~-insulin. 
Measurement of Total, IntraceUular, and 
Surface-Bound tzI-Insulin 
Isolated rat adipocytes (~400,000 ceUs/ml) were incubated with 0.3 ng/ml 
~251-insulin in MEM, 10 mM Hepes, 1% BSA, pH 7.6, at 37°C in the pres- 
ence or absence of protease inhibitors and substrate analogues. Most of the 
protease substrate analogues were first dissolved in dimethyl sulfoxide, 
producing 0.1-0.5 % dimethyl sulfoxide in the final incubation. Dimethyl 
sulfoxide at this concentration had no effect on insulin binding, internaliza- 
tion, or degradation. Nonspecific binding was determined by performing 
parallel incubations in the presence of 50 gg/ml unlabeled porcine insulin. 
At the indicated times, three 200-~tl aliquots were withdrawn for determina- 
tion of  total cell-associated radioactivity.  Each 200-txl aliquot of cell suspen- 
sion was added to a plastic microfuge tube containing 150 Ixl of silicone oil 
and the tubes were centrifuged for 30 s in a microfuge (model 11; Beckman 
Instruments, Inc., Fullerton, CA). This results in the separation (by the sili- 
cone oil) of the cell layer from the aqueous layer containing free unbound 
~25I-insulin. The cell plug (top layer) was then removed and the radioactiv- 
ity  measured.  Since total  cell-associated t251-insulin at  37°C  represents 
both surface (receptor) bound and internalized insulin, the amount of ~2sI- 
insulin in each of these cellular compartments was determined using a 
modification (21, 33) of an acid extraction procedure (19) that rapidly and 
quantitatively removes surface-bound insulin, leaving behind intracellular 
insulin. 1 ml of cell suspension was centrifuged in a 17 x  100-mm polysty- 
rene tube for 30 s at 200 rpm, after which the infranatant was removed and 
replaced with an equal volume (850 txl) of ice-cold barbital sodium acetate 
buffer, pH 3.0, containing 28 mM Na acetate, 20 mM Na barbital, and 117 
mM NaCI. After further incubation for 6 min at 4"C, three 200-1xl aliquots 
were removed and the remaining cell-associated (nonextractable) ~25I-in- 
sulin was measured after centrifugation of the ceils through silicone oil. Ex- 
tractable  125I-insulin was  then  calculated  by  subtracting  nonextractable 
binding from total binding. By this method, the acid-extractable radioactiv- 
ity represents ~25I-insulin bound to cell surface receptors while the nonex- 
tractable radioactivity represents insulin that has been internalized. 
Measurement of uSI-lnsulin Degradation 
The degradation of 125I-insulin was determined by assessing the precipita- 
bility of 1251-material from the incubation medium with 10% trichloroace- 
tic acid. With this method, trichloroacetic acid-precipitable material is con- 
sidered to be predominantly intact insulin and trichloroacetic acid-soluble 
material is considered to be degraded insulin (16, 28). 
Photoa~inity Labeling of  CeU Surface Insulin 
Receptors and Internalization of the Labeled 
Insulin-Receptor  Complexes 
Suspensions of isolated adipocytes (I  ×  106 cells/ml) were incubated in the 
dark at 14°C with 60 ng/rnl of NAPA-DP-12~I-insulin.  After 30 min of in- 
cubation, the cells were transferred to 60 x  15-mm plastic petri dishes and 
photolysis was carried out for 3 min by exposure to a long wave (366-nm) 
ultraviolet lamp (Blak-Ray;  Ultra-Violet Products, Inc., San Gabriel, CA) 
placed l0 cm from the cell suspension. These procedures covalenfly cross- 
link 25 % of the specifically  bound NAPA-DP-t~I-insulin to the cell surface 
insulin receptors without altering cell viability (6, 7). To initiate internaliza- 
tion of the labeled insulin-receptor complexes, adipocytes photolabeled at 
14°C were washed and incubated in fresh buffer at 37°C.  Aliquots of the 
cells were taken at various times and exposed to 200 txg/mi of trypsin for 
2 min at 37°C.  This trypsinization procedure affords an effective means of 
distinguishing between labeled receptors remaining on the cell surface that 
are sensitive to tryptic proteolysis and those that have been internalized and, 
therefore, become insensitive to the extracellular trypsin (6, 7). After the 
2-min exposure to trypsin, soybean trypsin inhibitor (final concentration, 
400 I.tg/ml) was added and the cells were then washed three times and sol- 
ubilized with a solution consisting of 3% SDS, 2 mM N-ethylmaleimide, 
2 mM phenylmethylsulfonyl  fluoride, and 5 mM ethylenediaminetetraacetic 
acid. 
Identification of  Solubilized PhotoaJ~inity-labeled 
Insulin Receptors 
The solubilized proteins from the photoaffinity-labeled cells were analyzed 
under nonreducing conditions by SDS PAGE according to the method of 
Laemmli (25), using porous acrylamide gels as described previously (6, 7). 
The gels were stained with Coomassie Brilliant Blue, destained, dried, and 
The Journal of Cell Biology, Volume 103, 1986  1808 autoradiographed at -70°C using X-Omat AR film (Eastman Kodak Co., 
Rochester, NY) and Cronex Lightning Plus (Dupont Co., Diagnostic & Bio- 
Research  Systems, Wilmington,  DE)  intensifying screen.  The  relative 
molecular mass (Mr)  markers  used were fibronectin (440  kD),  myosin 
(200 kD),  fl-galactosidase (116.5 kD), phosphorylase B (92.5 kD), bovine 
serum albumin (66 kD), and ovalbumin (45  kD). 
Results 
Effects of  Protease and Transglutaminase Inhibitors 
on Insulin Internalization 
Using the acid-barbital extraction technique for quantitation 
of intracellular insulin,  a  variety of inhibitors of different 
classes of proteases (2) and transglutaminase inhibitors (12, 
19) were studied for their effects on the internalization of 
~25I-insulin in adipocytes incubated at 37°C  (Table I).  The 
concentrations of the compounds used in these initial studies 
were determined from the known inhibitory concentrations 
of these agents as used in various other studies.  The first 
group of compounds tested were competitive inhibitors of 
metalloendoproteases (Table I, group 1 compounds), agents 
that have previously been shown to inhibit exocytosis (3, 31). 
The  substrate  analogues  (Cbz-Gly-Phe  amide,  Cbz-Leu 
amide)  and  the  nonsubstrate  competitive inhibitor  (phos- 
phoramidon) of metalloendoproteases did not inhibit insulin 
internalization in adipocytes but instead caused increased 
intracellular  accumulation  of  ~25I-insulin (Table I).  Simi- 
larly, a series of competitive inhibitors of trypsin-like serine 
proteases and thiol cathepsins (Table I, group 2 compounds) 
also did not inhibit insulin internalization but caused variable 
degrees of increase in the intracellular accumulation of ~25I- 
insulin. Among this group of inhibitors, benzoyl-Arg ethyl 
ester and tosyl-Arg methyl ester have previously been shown 
to inhibit various insulin effects in adipocytes, including in- 
sulin stimulation of receptor phosphorylation, glucose trans- 
port, glucose oxidation, and lipogenesis (4, 9, 30, 39) at con- 
centrations (5  mM)  identical to those used in the present 
studies. Leupeptin and pepstatin are microbial-derived non- 
substrate competitive inhibitors of serine/thiol and carboxyl 
proteases,  respectively,  and  neither  of these  compounds 
influenced the amounts of intracellular ~25I-insulin in adipo- 
cytes (Table I, group 3). 
Of the  various  competitive inhibitors  of endoproteases 
tested,  only N-acetyl-Tyr ethyl ester, a  substrate analogue 
of chymotrypsin-like serine proteases  (20),  markedly de- 
creased the intracellular accumulation of ~25I-insulin in adi- 
pocytes (Table I, group 4). In the presence of 1 mM N-acetyl- 
Tyr ethyl ester, intracellular insulin accumulated to only 15 % 
of values reached in parallel control incubations. 
A series of inhibitors of exoproteases (2) were also studied 
for their effects on insulin internalization. As shown in Table 
I, competitive inhibitors (substrate analogues) of aminopep- 
tidases (group 5), carboxypeptidases (group 6), and di- and 
tripeptidases (group 7) did not inhibit insulin internalization 
but caused variable increases in the amount of intracellular 
~25I-insulin. Similarly, the transglutaminase inhibitors dan- 
sylcadaverine and methylamine did not inhibit the internal- 
ization of insulin into adipocytes. 
The results summarized in Table I show that of the various 
inhibitors tested, only N-acetyl-Tyr ethyl ester, a competitive 
inhibitor (substrate analogue) of chymotrypsin-like enzymes 
inhibited  the  receptor-mediated endocytosis of insulin  in 
Table L Effects of  Protease and Transglutaminase 
Inhibitors on Insulin Internalization in Rat Adipocytes 
Internalized  insulin 
Inhibitors  Concentration  (percent of control) 
mM 
Competitive inhibitors of endoproteases 
None (control) 
1. 
100 
2. 
Cbz-Gly-Phe amide  5.0  354  +  40 
Cbz-Gly-Leu amide  5.0  227  +  8 
Phosphoramidon  0.1  301  +  21 
TosyI-Arg methyl ester  5.0  156 +  5 
Benzoyl-Arg ethyl ester  5.0  136 +  3 
Benzoyl-Arg amide  5.0  130 +  17 
Benzoyl-Arg-nitroanilide  2.0  338 +__ 46 
Benzoyl-DL-Arg-[i-napthylamide  0.3  122 + 6 
3.  Leupeptin  0,1  99  +  4 
Pepstatin  0.003  99  +  1 
4. N-acetyl-Tyr ethyl ester  1.0  15  +  1 
Competitive inhibitors of exoproteases 
5. Leu-NH2  5.0  156 +  15 
Cbz-Gly-Gly amide  5.0  124 + 3 
6.  Cbz-Glu-Tyr  5.0  181  +  3 
Cbz-Pro-Phe  5.0  158  +  8 
Gly-Leu  5.0  105  +  14 
Ala-Gly  5.0  115  ___  8 
Ser-Met  5.0  112  +  5 
Gly-Gly-Gly  5.0  97  +  6 
7. 
Transglutaminase inhibitors 
8.  Methylamine  15.0  174  +  24 
Dansylcadaverine  0.2  115  ___ 4 
Adipoctyes were incubated for 60 min at 37°C with 0.3 ng/ml of mI-insulin 
either in the absence or presence of the various  inhibitor  compounds shown. 
The amount of internalized insulin was then quantitated after dissociation of the 
surface-bound insulin using acid-barbital buffer. The results, expressed as per- 
cent of the amount of insulin internalized  in control cells, represent the mean 
+  SEM of three to four separate  experiments. 
adipocytes. Therefore, the effects of this agent on the inter- 
nalization process were further characterized. 
Effect of  N-acetyl-~yr ethyl ester Concentration on 
Insulin Binding and Internalization 
Fig.  1 shows the effects of increasing concentrations of N-ace- 
tyl-Tyr ethyl ester on total, surface-bound, and intracellular 
cell-associated  insulin.  At  concentrations  of N-acetyl-Tyr 
ethyl ester greater than 0.25 raM, large dose-dependent de- 
creases in the intracellular accumulation of ~/sI-insulin were 
observed. During the 60-min incubation, the amount of in- 
ternalized insulin decreased by 50 and 87 % in the presence 
of 0.55 mM and  1.0 mM N-acetyl-Tyr ethyl ester, respec- 
tively. Nonspecific binding was not changed in the presence 
of  1  mM  N-acetyl-Tyr ethyl ester  during  the  incubation 
period. Additionally, cell viability as assessed by stability of 
adipocyte counts and the ability of the cells to exclude trypan 
blue remained unaltered during the same incubation period. 
Internalization  remained  suppressed  at  concentrations  of 
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Figure 1. Effect of N-acetyl-Tyr ethyl ester concentration on total, 
intracellular,  and  surface-bound  insulin.  Adipocytes were  incu- 
bated for 60 min at 37°C with 0.3 ng/ml ~25I-insulin in the absence 
or presence of the indicated concentrations  of N-acetyl-Tyr ethyl 
ester.  Total (o),  intracellular  (e),  and  surface-bound  (zx) cell- 
associated insulin were then determined in triplicate and corrected 
for nonspecific binding. The mean + SEM of three separate experi- 
ments are shown. 
N-acetyl-Tyr ethyl ester higher than  1 mM; however, pro- 
longed incubation with these higher concentrations caused 
increased nonspecific binding.  Total cell-associated ~25I-in- 
sulin was consistently increased in the presence of the vari- 
ous  concentrations  of N-acetyl-Tyr ethyl  ester,  including 
those that resulted in submaximal inhibition of insulin inter- 
nalization.  Surface-bound  insulin  was  also  markedly  in- 
creased with the maximal increase (280%) occurring at 0.55 
mM N-acetyl-Tyr ethyl ester, the concentration at which in- 
tracellular insulin accumulation was decreased by 50%. 
To determine if N-acetyl-Tyr ethyl ester has any effect on 
cell surface insulin-binding independent of its effect on inter- 
nalization, adipocytes were first incubated at 37°C for 30 min 
in the absence or presence of 1 mM N-acetyl-Tyr ethyl ester. 
After cooling the cells to 12°C, insulin binding (total, intra- 
cellular, and cell surface) was determined at this temperature 
in the presence of increasing hormone concentrations.  As 
shown in Fig. 2, intracellular insulin accumulation was small 
at 12°C,  reflecting the slow internalization of insulin at this 
temperature (33).  Surface-bound ~25I-insulin was the same 
in treated  and control  cells.  Scatchard analysis of surface 
binding (data not shown) indicated that cell surface receptor 
number and affinity were identical in the presence or absence 
of N-acetyl-Tyr ethyl ester. 
I~me Course of the Effect of  N-acetyl-1~ ethyl ester 
on Insulin Binding and Internalization 
Fig. 3 shows the time course of the effects of 1 mM N-acetyl- 
Tyr ethyl ester on total, intracellular, and surface-bound in- 
sulin in adipocytes incubated at 37°C. Total binding (Fig.  3 
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Figure 2. Lack of effect of N-acetyl-Tyr ethyl ester on binding of 
125I-insulin to adipocytes at  12°C. Adipocytes were incubated for 
30 min at 37°C in the absence (o, zx) or presence (e, A) of 1 mM 
N-acetyl Tyr ethyl ester. The cells were then cooled to 12°C and 
0.2 ng/ml 125I-insulin plus sufficient unlabeled insulin were added, 
giving the indicated final concentrations of the hormone. After fur- 
ther incubation at 12°C for 150 min, total, intracellular and surface- 
bound  125I-insulin were determined  in triplicate.  The data shown 
represent the mean of cell surface bound (o, e) and intracellular 
(zx, A) ~25I-insulin from three separate experiments. 
A) became maximal after 15-30 min of incubation in both 
control and treated cells. Levels of total binding were similar 
in the two groups between 5 and 30 min of incubation, after 
which total binding was greater in cells treated with N-ace- 
tyl-Tyr ethyl  ester.  Intracellular  t25I-insulin  accumulation 
(Fig. 3 B) was rapidly and markedly reduced in N-acetyl-Tyr 
ethyl ester-treated cells such that during the first 30 min of 
incubation it was only 5 % of that attained in control cells. 
Subsequently, a gradual small rise occurred in intracellular 
insulin in the treated cells, possibly as a consequence of hy- 
drolysis of a fraction of N-acetyl-Tyr ethyl ester in the incu- 
bations such that its effective concentration is lowered to a 
level that would be submaximal in inhibiting internalization 
(See Fig.  1).  Surface insulin binding was maximal between 
15 and 30 min in both N-acetyl-Tyr ethyl ester-treated and 
untreated  cells,  but  the  amount  of surface-bound  insulin 
was approximately doubled in the N-acetyl-Tyr ethyl ester- 
treated cells (Fig. 3 C). Thus, with the inhibition of insulin 
internalization by N-acetyl-Tyr ethyl ester (B),  a  large in- 
crease in the amount of surface-bound insulin (C) was ob- 
served. 
Effect of  N-acetyl-1~r ethyl ester on Insulin Degradation 
Fig. 4 shows the time course of insulin degradation in the in- 
cubation medium in the presence and absence of N-acetyl- 
Tyr  ethyl  ester,  as  determined  by  trichloroacetic  acid 
precipitability of ~25I-insulin. During the 90 rain of incuba- 
tion at 37°C,  insulin degradation was consistently lower in 
the N-acetyl-Tyr ethyl ester-treated cells as compared with 
the control cells. The percent insulin degradation in the con- 
trol incubations represented 16.9 +  2.7 % at 60 min and 23.2 
+  1.7%  at 90 min,  while in the presence of N-acetyl-Tyr 
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Figure 3. Effect of N-acetyl-Tyr  ethyl ester on the time course of 
insulin  binding and internalization.  Adipocytes  were incubated  at 
37°C with 0.3 ng/ml of 125I-insulin in the absence (o)  or presence 
(e) of 1 mM N-acetyl-Tyr ethyl ester. Aliquots of the cells were re- 
moved at the indicated times for measurement of total (A), intracel- 
lular (B), and surface-bound (C) specific cell-associated  radioac- 
tivity. Each data point represents  the mean +  SEM of the percent 
~25I-insulin specifically associated  with 4  ×  105 adipocytes in three 
separate  experiments. 
ethyl ester, the corresponding amounts were 14.1 +  2.2 and 
19.5  +  1.9% at 60 and 90 min, respectively. The differences 
in insulin degradation between the control and treated cells 
at  each  of these  two  incubation  periods  were  statistically 
significant at P  <  0.01 level. 
Effects of N-acetyl-~r ethyl ester in Inhibiting the 
Chloroquine-mediated Increase in Intracellular Insulin 
To further determine the effect of N-acetyl-Tyr ethyl ester on 
the  internalization  and  intracellular  processing  of insulin, 
experiments were performed in the absence or presence of 
chloroquine, a lysosomotropic agent that blocks the process- 
ing of internalized insulin and causes a marked increase in 
intracellular insulin accumulation (21, 28, 33). Thus, under 
conditions  in  which  insulin  internalization  is  inhibited,  a 
chloroquine-mediated increase in intracellular insulin should 
not occur. This is shown in Fig. 5. During a 60-min incuba- 
tion of adipocytes at  37°C  in the  absence  of N-acetyl-Tyr 
ethyl ester,  chloroquine (0.1  mM) caused a 250%  increase 
in intracellular  ]25I-insulin.  By contrast,  in the presence of 
N-acetyl-Tyr ethyl ester, insulin internalization was inhibited 
and chloroquine failed to cause an increase in intracellular 
insulin  (Fig.  5). 
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Figure 4.  Effect  of N-acetyl- 
Tyr  ethyl  ester  on  insulin 
degradation by rat adipocytes 
at 37°C.  Adipocytes  were in- 
cubated at 37°C with 0.3  ng/ 
ml mI-insulin in the absence 
(o) or presence (e) of 1 mM 
N-acetyl-Tyr  ethyl  ester.  At 
the times  shown,  the percent 
of  ~25I-insulin degraded  (tri- 
chloroacetic acid-soluble)  was 
determined.  The data  shown 
represent  the mean -1- SEM of 
five separate  experiments. 
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Figure 5.  Effect  of N-acetyl- 
Tyr ethyl ester on the chloro- 
quine-mediated  increase of in- 
tracellular  mI-insulin. Adipo- 
cytes were incubated  with 0.3 
ng/ml of ~5I-insulin  at  37°C 
with:  no  further  additions, 
chloroquine (100 IxM), N-ace- 
tyl-Tyr-ethyl ester (1 mM), or 
chloroquine  (100 gM)  plus 
N-acetyl-Tyr-ethyl  ester (1 mM). 
After 1 h of incubation,  non- 
extractable (intracellular)  cell- 
associated  radioactivity  was 
determined in triplicate.  Data 
shown represent mean + SEM 
of three separate experiments. 
Reversibility of the N-acetyl-1)#" ethyl ester-induced 
Inhibition of  Insulin Endocytosis 
To determine the reversibility of the inhibition of insulin in- 
ternalization  by N-acetyl-Tyr ethyl  ester,  adipocytes  were 
first incubated for 30 min at 37°C with  1 mM N-acetyl-Tyr 
ethyl ester.  Under  these  conditions  insulin  internalization 
was inhibited to 10 % of that in control cells (Fig.  6).  After 
removal of  N-acetyl-Tyr ethyl ester by washing and resuspen- 
sion  of the  cells  in  fresh buffer,  the  adipocytes  gradually 
regained most of their ability to internalize insulin, such that 
4 h after washing the treated adipocytes internalized insulin 
with  •70%  of the efficiency of control cells (Fig.  6). 
StructuraI Requirements for Inhibition of  Insulin 
Endocytosis by N-acetyl-7~jr ethyl ester 
It was of importance to determine whether the full structural 
complement of the chymotrypsin substrate analogue, N-ace- 
tyl-Tyr ethyl ester, is required for its inhibition of insulin in- 
ternalization or whether fragments of the molecule have any 
effect. Therefore, the effects on insulin binding and internal- 
ization of fragments of N-acetyl-Tyr ethyl ester  (N-acetyl- 
Tyr, Tyr, and Tyr ethyl ester) were measured.  N-acetyl-Tyr 
and  Tyr are  not substrates  since they lack a  hydrolyzable 
bond on the carboxyl group and since Tyr ethyl ester has a 
free unblocked amino group and is a weak substrate for chy- 
motrypsin, an enzyme with predominantly endoprotease ac- 
100 
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A-TyrEE removed 
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Figure 6. Reversibility  of the 
effect of N-acetyl-Tyr ethyl es- 
ter.  Adipocytes  were  incu- 
bated for 30 rain at 37°C in the 
absence (control) or presence 
of  1  mM  N-acetyl-Tyr-ethyl 
ester. The untreated and treated 
cells  were then washed  three 
times  and  resuspended  in 
fresh buffer at 37°C. At the in- 
dicated  times  after  washing, 
aliquots  of cells  were  taken 
and incubated  for 30 min at 37°C with 0.3 ng/ml ~25I-insulin, after 
which intracellular  insulin was determined. At each time point in- 
tracellular  insulin  accumulation  in  cells  previously  exposed  to 
N-acetyl-Tyr ethyl ester was compared with that found in the paral- 
lel control incubation. 
Jochen and Berhanu Chymotrypsin Substrate Analogues Block Endocytosis  1811 Table II. Structural Requirements  for Inhibition of  lnsulin 
Internalization by N-acetyl- Tyr ethyl ester 
Cell-associated insulin 
(percent of control) 
Addition  Total  lntracellular  Surface 
N-Acetyl-Tyr ethyl Ester 
(1  mM)  96  +  12  4  +  2  145  +  5 
N-Acetyl-Tyr (5 mM)  103  +  21  105  -t-  18  105  +  23 
Tyrosine (5 mM)  101  +  20  113  +  17  93  +  17 
Tyr ethyl ester (2  mM)  89  +  4  89  +  8  90  +  2 
Adipocytes were incubated for 30 min at 37°C with 0.3 ng/ml of ~251-insulin 
in the presence or absence of the various modified tyrosine compounds. Total, 
surface-bound, and intracellular insulin were then quantitated. Results shown 
represent the mean +  SEM of three separate experiments. 
tivity (2, 20). Table II shows that while the intact N-acetyl- 
Tyr ethyl ester molecule inhibited insulin internalization to 
4%  of that in control cells,  its fragment compounds did 
not significantly decrease internalization even when these 
compounds were used at concentrations higher than that of 
N-acetyl-Tyr ethyl ester. 
Effects of Different Chymotrypsin  Substrate 
Analogues on Insulin Internalization 
To determine if other chymotrypsin substrate analogues be- 
sides N-acetyl-Tyr ethyl ester inhibit insulin internalization, 
the effects of four additional substrate compounds were stud- 
ied. Table III shows that N-acetyl-Phe ethyl ester, N-acetyl- 
Trp  ethyl ester,  and  benzoyl-Tyr ethyl ester,  compounds 
which are  all chymotrypsin substrate analogues (20),  in- 
hibited insulin internalization by 83-92 %.  This magnitude 
of inhibition was similar to that which occurred with N-ace- 
tyl-Tyr ethyl  ester,  although  the  concentrations  required 
for maximal inhibition differed among the various agents. 
Benzoyl-Tyr amide,  another  chymotrypsin substrate  ana- 
logue (20),  was tested at 10 mM, the highest concentration 
at which it is soluble, and resulted in a 62 % decrease in insu- 
lin internalization. Thus, chymotrypsin substrate analogues 
with Tyr, Phe, or Trp as the amino acid, N-acetyl or benzoyl 
groups as the amino-terminal blocking group, and ethyl ester 
or amide as the carboxyl-terminal blocking group were all 
effective inhibitors of internalization (Table III). 
Effects of Chymotrypsin  Substrate Analogues 
on  the Internalization of  Photoaffinity-labeled 
Insulin Receptors 
The experiments described thus far examined the effects of 
the chymotrypsin substrate analogues on the internalization 
of surface-bound '25I-insulin. If these effects are due to inhi- 
bition of receptor-mediated endocytosis, then internalization 
of the cell surface insulin receptors should also be inhibited. 
To verify this, the effects of the various substrate analogues 
on the internalization of  photoaflinity-labeled  cell surface in- 
sulin receptors were studied. After photoaffinity-labeling of 
the surface insulin receptors with ~25I-NAPA-DP-insulin at 
14°C, endocytosis was initiated by warming the cells to 37°C. 
The subsequently internalized insulin-receptor complexes 
were distinguished from the complexes remaining on the cell 
surface by the sensitivity of the latter to tryptic digestion (6, 
7).  Fig.  7  shows the time course of internalization of the 
specifically photoaffinity-labeled  nonreduced cell surface in- 
Table Ill. Effects of Chymotrypsin Substrate Analogues 
on Insulin Binding and Internalization in Rat Adipocytes 
Cell-associated insulin 
(percent of control) 
Addition  Total  Intracellular  Surface 
N-acetyl-Tyr ethyl ester 
(1  mM)  98  +  12  4  +  2  179  +  14 
N-acetyl-Phe ethyl ester 
(0.75  mM)  95  +  10  8  +  4  160  +  2 
N-acetyl-Trp ethyl ester 
(0.5  mM)  132  +  14  9  +  6  285  +  71 
Benzoyl-Tyr ethyl ester 
(0.2 mM)  96  +  17  17  +  6  166  +  23 
Benzoyl-Tyr amide 
(10 mM)  163  +  23  38  +  11  308  +  53 
Adipocytes were incubated for 30 min at 37°C with 0.3 ng/ml of ~25I-insulin 
in the presence or absence of the chymotrypsin substrate analogues. Total, 
surface-bound, and intracellular insulin were then quantitated.  Results shown 
represent the mean +  SEM of three or four separate experiments. 
sulin receptors (Mr 440,000).  In the absence of N-acetyl-Tyr 
ethyl ester, progressive receptor internalization occurred as 
demonstrated by the time-dependent increase in the intensi- 
ties  of the  trypsin-insensitive  (intracellular)  Mr  440,000 
receptor bands (Fig. 7 A, lanes 1-5). In contrast, in the pres- 
ence of 1 mM N-acetyl-Tyr ethyl ester, the intensities of the 
trypsin-insensitive Mr  440,000  bands  were  markedly de- 
creased (Fig. 7 A, lanes 6-10), indicating inhibition of recep- 
tor internalization. Although not directly quantitated, it is 
also evident from the autoradiogram in Fig. 7 A that the Mr 
140,000 receptor proteolytic fragments generated by trypsin 
from the labeled receptors remaining on the cell surface are 
more  intense  in  the  presence  of N-acetyl-Tyr ethyl ester 
(lanes 6-10) than in its absence (lanes 1-5).  This indicates 
that more of the labeled receptors were trapped on the cell 
surface by N-acetyl-Tyr ethyl ester. Direct quantitation of the 
internalized Mr 440,000  receptors (Fig. 7 B) demonstrates 
that N-acetyl-Tyr ethyl ester decreased the internalization of 
photoaflinity-labeled  cell surface insulin receptors by ,~90 %. 
Fig. 8 shows the effects of the various chymotrypsin sub- 
strate analogues on the endocytosis of photoaflinity-labeled 
insulin-receptor complexes. N-acetyl-Tyr ethyl ester, N-ace- 
tyl-Phe ethyl ester,  N-acetyl-Trp  ethyl ester,  benzoyl-Tyr 
ethyl ester, and benzoyl-Tyr amide all inhibited the intracel- 
lular translocation of insulin-receptor complexes by ,o'/0-90% 
in direct proportion to the ability of these agents to inhibit 
125I-insulin internalization as determined by the acid-barbi- 
tal extraction technique (Table III). 
Discussion 
From the data presented in this study, several  lines of evi- 
dence indicate that synthetic peptides that are specific sub- 
strate analogues of chymotrypsin-like enzymes inhibit the 
endocytotic uptake of insulin-receptor complexes into iso- 
lated rat adipocytes. First, of the various protease and trans- 
glutaminase inhibitors tested, only the chymotrypsin sub- 
strate analogues inhibited insulin internalization (Tables  I 
and III). Secondly, as determined for the analogue that we 
studied in detail, N-acetyl-Tyr ethyl ester, inhibition of inter- 
nalization  required  the  full  structural  complement  of  a 
chymotrypsin substrate analogue (20), since fragments of  the 
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Tyr  ethyl  ester  on  the  time 
course  of  internalization  of 
photoaflinity-labeled  insulin 
receptors.  (A)  Insulin  recep- 
tors on the surface of isolated 
rat  adipocytes  were  photoaf- 
finity-labeled with 125I-NAPA- 
DP  insulin  at  14°C. The  la- 
beled cells  were  washed and 
then incubated at 37°C to initi- 
ate internalization.  At the in- 
dicated  times,  the cells  were 
trypsinized to degrade surface 
receptors,  washed,  and  solu- 
bilized.  The  samples  were 
then  analyzed by electropho- 
resis  and  autoradiography 
under disulfide nonreducing conditions.  These procedures were performed in the absence (lanes 1-5) or presence (lanes 6-10) of 1 mM 
N-acetyl-Tyr ethyl ester.  (B) The areas of the dried gel containing the trypsin-insensitive (intracellular) Mr 440,000  receptor bands were 
cut out from the dried gel and the radioactivity measured in a gamma counter for the control (o) and 1 mM N-acetyl-Tyr ethyl ester-treated 
cells (o). 
N-acetyl-Tyr ethyl ester molecule were all without effect on 
internalization (Table II). Thirdly, while decreasing intracel- 
lular  insulin  accumulation,  the  substrate  analogues  caused 
large increases in surface-bound insulin (Figs.  1 and 3; Table 
III),  indicating  sequestration  of receptor-bound  insulin  on 
the  cell  surface.  Additionally,  N-acetyl-Tyr ethyl  ester  in- 
hibited the chloroquine-mediated increase in intracellular in- 
sulin  (Fig.  5),  thus  indicating  that the  substrate  analogues 
prevented the delivery of surface-bound insulin to intracellu- 
lar  chloroquine-sensitive  sites.  Fourth,  the  studies  with 
receptor photoaffinity labeling  (Figs.  7  and  8) cleai'ly dem- 
onstrate that the chymotrypsin substrate analogues inhibit in- 
ternalization  of covalent  insulin-receptor  complexes.  Fur- 
thermore,  the  degree  of  this  inhibition  by  the  different 
substrate  analogues  (Fig.  8)  closely parallels  the degree to 
which  they  inhibited  125I-insulin  internalization  as  deter- 
mined by the independent technique of acid-barbital extrac- 
tion of surface-bound insulin (Table III). This direct correla- 
tion between inhibition of ligand and receptor internalization 
strongly indicates that the chymotrypsin substrate analogues 
inhibit  receptor-mediated  endocytosis. 
The inhibition of internalization by the chymotrypsin sub- 
strate analogues is unlikely to be due to nonspecific cell tox- 
icity, since cell viability, as ascertained by adipocyte counts, 
trypan blue exclusion,  and nonspecific insulin binding,  was 
unaltered  in  the  presence  of the  agents.  Additionally,  the 
analogue-induced  inhibition  of internalization  was  largely 
reversible  (Fig.  6).  While  the  reason  for  the  incomplete 
recovery of internalization  is not clear,  one possibility may 
be the persistent interaction of a residual amount of the inhib- 
itor with adipocyte target proteins. Alternatively, after maxi- 
mal inhibition,  the complete recovery of internalization may 
depend on slow cellular processes,  such as new synthesis of 
protein  and/or  lipid  components  of the  internalization  ap- 
paratus.  The fact that several of the compounds that are not 
substrates  for  chymotrypsin  (Table  I),  but  are  esters  or 
amides  like the chymotrypsin  substrate  analogues,  did  not 
inhibit  insulin  internalization  is  further  evidence  against 
nonspecific cell toxicity as the cause of the observed inhibi- 
tion of internalization.  Thus, of the ester compounds tested, 
the chymotrypsin substrate analogues, N-acetyl-Tyr ethyl es- 
ter, N-acetyl-Phe ethyl ester, and benzoyl-Tyr ethyl ester, all 
inhibited insulin internalization (Table III) while the nonsub- 
strate  esters,  tosyl-Arg methyl ester and  benzoyl-Arg ethyl 
ester,  failed to inhibit  (Table I,  group  2).  Similarly,  of the 
amide compounds tested,  benzoyl-Tyr amide, a chymotryp- 
sin substrate analogue (20),  inhibited  insulin internalization 
Figure 8.  Effect of chymotrypsin substrate analogues on the intra- 
cellular accumulation of photolabeled insulin  receptors. Isolated rat 
adipocytes  were  photolabeled  at  14°C, washed,  and  further  in- 
cubated in fresh buffer at 37°C with:  no additions (control, lane 1 ), 
1 mM N-acetyl-Tyr ethyl ester (A-TyrEE, lane 2); 0.75 mM N-ace- 
tyl-Phe ethyl ester (A-PheEE, lane 3); 0.5 mM N-acetyl Trp ethyl 
ester  (A-TrpEE,  lane  4);  0.2  mM  benzoyl-Tyr ethyl  ester  (Bz- 
TyrEE, lane 5); and 10 mM benzoyl-Tyr amide (Bz-Tyr NH2, lane 
6).  After 30 min the cells were trypsinized,  solubilized,  and the 
solubilized samples were then analyzed by SDS PAGE and autoradi- 
ography.  The  inset  shows  the  autoradiogram  of  the  trypsin- 
insensitive  (intracellular)  440-kD  insulin  receptors  and  the  bar 
graph shows quantitative profile of the radioactivity in the receptor 
bands as determined by gamma counting of areas of the gel contain- 
ing the 440-kD bands. 
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strate analogues for chymotrypsin-like enzymes failed to in- 
hibit insulin internalization (Table I, amides in group 1, 2, 
and 5). While these series of data argue against nonspecific 
cell toxicity being the reason for inhibition of internalization 
by the chymotrypsin substrate analogues, they do not rule out 
the possibility that these agents may also be influencing mul- 
tiple cellular processes in addition to their inhibition of en- 
docytosis. 
The effect of  N-acetyl-Tyr ethyl ester on surface-bound in- 
sulin is of interest in that surface binding was approximately 
doubled under conditions where insulin internalization was 
inhibited (Figs. 1 and 3). Inhibition of endocytosis in alveo- 
lar  macrophages  by  phenylarsine oxide  similarly  causes 
large increases in the number of surface receptors for several 
ligands and this increase was attributed to intracellular re- 
ceptor pools being recruited to the cell surface (22).  The in- 
crease in surface insulin binding that we observed is unlikely 
to be the result of a  similar fusion of intracellular insulin 
receptor pools with the cell surface for two reasons. Insulin 
binding was not increased when cells were first incubated 
with N-acetyl-Tyr ethyl ester at 37°C and then cooled to 12°C 
to determine cell surface receptor number and affinity (Fig. 
2). In addition, the size of intracellular insulin receptor pool, 
•10-15  % of  total cellular receptors in adipocytes (18, 29, 38), 
is not large enough to account for the twofold increase in sur- 
face binding observed in the presence of chymotrypsin sub- 
strate analogues. The increase in surface binding is also not 
likely to be the result of a direct effect of chymotrypsin sub- 
strate analogues on cell surface receptors, since binding was 
not increased at 12°C in the presence of N-acetyl-Tyr ethyl 
ester (Fig. 2). A more likely explanation is that most of the 
increase in  surface binding is the result of inhibiting the 
insulin-induced redistribution of surface receptors to intra- 
cellular sites,  a process that normally occurs in adipocytes 
(18, 29, 38). The additional possibility also exists that inhibi- 
tion of  endocytosis may be causing an indirect increase in ap- 
parent receptor affinity  as predicted from mathematical mod- 
eling of receptor-mediated endocytosis (23). 
The effects of N-acetyl-Tyr ethyl ester on insulin process- 
ing and degradation (Figs. 4 and 5) lend further support to 
the view that this compound inhibits receptor-mediated insu- 
lin internalization. Chloroquine, a lysosomotropic agent (28, 
33), was without effect on intracellular insulin accumulation 
in N-acetyl-Tyr ethyl ester-treated cells, while it tripled in- 
tracellular insulin in nontreated cells (Fig. 5). This finding 
indicates that by inhibiting endocytosis, N-acetyl-Tyr ethyl 
ester prevented the delivery of extracellular insulin to intra- 
cellular chloroquine-sensitive sites  and also demonstrates 
that N-acetyl-Tyr ethyl ester acts by a mechanism different 
from that of  chloroquine, a drug that inhibits insulin process- 
ing intracellularly (28, 33). The 15-20%  decrease in insulin 
degradation  caused  by  N-acetyl-Tyr ethyl  ester  (Fig.  4) 
reflects that portion of overall degradation that is mediated 
by endocytosis and intracellular processing. In this regard, 
our finding is consistent with previous reports showing that 
overall insulin degradation in rat adipocyte suspensions oc- 
curs predominantly by nonreceptor-mediated processes (16). 
The fact that several of the compounds that did not inhibit 
endocytosis caused significant increases in intracellular insu- 
lin (Table I) is of interest. As a group, this effect was most 
marked for the metalloendoprotease inhibitors, Cbz-Gly-Phe 
amide, Cbz-Gly-Leu amide, and phosphoramidon (Table I, 
group 1) agents that have previously been shown to inhibit 
exocytotic processes (3, 31). Since a portion of internalized 
insulin in adipocytes is processed by retroendocytosis (28), 
which  involves  an  exocytotic step,  it is possible  that the 
effects of the metalloendoprotease substrates in causing an 
increase in the internalized pool of insulin (Table I) may be 
a consequence of their inhibiting the retroendocytosis of in- 
ternalized insulin. 
It is also of interest to note that the substrate analogues of 
trypsin-like proteases, tosyl-Arg methyl ester and benzoyl- 
Arg ethyl ester, which did not inhibit insulin internalization 
(Table I, group 2),  have previously been shown to inhibit 
phosphorylation of the insulin receptor (39). In contrast, the 
chymotrypsin substrate analogue, N-acetyl-Phe ethyl ester, 
which is shown in the present study as inhibiting internaliza- 
tion of insulin (Table III) and insulin receptors (Fig. 8), had 
previously been found to have little effect on insulin receptor 
phosphorylation  (39).  This  apparent  divergence  between 
effects on internalization of insulin-receptor complexes and 
phosphorylation of the receptors  suggests  that insulin re- 
ceptor phosphorylation is not a  necessary step  for its  in- 
ternalization. This view is further supported by the recent 
demonstration that phosphorylation is not required for re- 
ceptor-mediated internalization of growth hormone in 1M-9 
lymphocytes (1). 
The transglutaminase inhibitors methylamine and dansyl- 
cadaverine did not block receptor-mediated uptake of insulin 
into adipocytes (Table I), confirming recent similar observa- 
tions (14). Since transglutaminase inhibitors may prevent the 
endocytosis of other ligands into different cell types (12, 19), 
their lack of effect in  adipocytes indicates that there  are 
differences in the mechanisms of internalization of different 
ligands by different cell types. In this regard, the low density 
lipoprotein receptor is initially clustered in clathrin-coated 
pits on the cell surface of fibroblasts and is internalized in 
a constitutive manner, that is, the receptor is internalized in 
the presence or absence of  ligand (17). In contrast, the insulin 
receptor on adipocytes is distributed more diffusely on the 
cell surface and a role for clathrin-coated pits remains to be 
demonstrated (37). Furthermore, the internalization of the 
insulin receptor in adipocytes is a partly inductive process, 
since the  number of intracellular insulin receptors  is  in- 
creased in the presence of insulin (18, 29, 38).  Whether the 
chymotrypsin substrate analogues exert their effects only on 
the endocytosis of insulin and insulin receptors in adipocytes 
because of such differences or whether they prove to be in- 
hibitors of the endocytosis of other ligands in different cell 
types remains to be determined. 
Although the basic mechanism by which the chymotrypsin 
substrate analogues inhibit internalization of insulin-recep- 
tor complexes is still unknown, certain general conclusions 
can be made based on the available data. Receptor-mediated 
endocytosis requires multiple steps (17, 43, 44), consisting of 
binding of the ligand to its receptor on the cell surface, trans- 
location of the ligand-receptor complexes to areas of the 
plasma membrane that form endocytotic vesicles, pinching 
off of the endocytotic vesicle from the plasma membrane, 
and finally, movement of the vesicle to its intracellular desti- 
nation(s).  Clearly, the inhibition of internalization by the 
chymotrypsin substrate analogues was not a consequence of 
decreased binding since surface binding was markedly in- 
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II and III). It is also not likely that the agents acted at a step 
distal to the pinching and closing off of the endocytotic vesi- 
cle from the cell surface, since insulin and its receptor would 
not be sensitive to the acid-barbital extraction procedure or 
to tryptic digestion after this step.  Thus, the chymotrypsin 
substrate analogues most likely inhibit the step(s) leading to 
the formation of endocytotic vesicles from the plasma mem- 
brane,  or any  step proximal to complete vesicle formation 
but distal  to the initial binding of insulin. The fact that the 
five compounds that inhibited the internalization of insulin 
(Table III) and insulin receptors (Fig. 8) are all chymotrypsin 
substrate  analogues  (20)  suggests  that their effect may  be 
mediated by inhibition of an endogenous chymotrypsin-like 
protease whose activity is required  in the endocytotic pro- 
cess, possibly in the initial formation or pinching off of en- 
docytotic vesicles from the plasma membrane. However, un- 
til  the  presence  of  a  chymotrypsin-like  protease  can  be 
demonstrated  in the  plasma membrane  of adipocytes,  the 
possibility remains that the substrate analogues could be in- 
hibiting internalization by other mechanism(s).  Regardless 
of the  molecular mechanism  involved,  chymotrypsin  sub- 
strate analogues efficiently block internalization  of insulin- 
receptor complexes and should prove useful in studying the 
functional consequences of insulin internalization  and in fur- 
ther  investigations  into  the  possible  role  of  endogenous 
chymotrypsin-like enzymes or related molecules in receptor- 
mediated endocytosis of insulin. 
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